A new collaboration is seeking to bring quantitative imaging analysis to diagnosis and care of patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD) and emphysema. The agreement is between Spesana, a healthcare platform focused on molecular diagnostics and in building an accessible database for physicians,…

Patients with chronic obstructive pulmonary disease (COPD) often have more acute episodes of symptom worsening (exacerbations) during the coldest months of the year — January, February, and March — resulting in higher hospitalization and mortality rates in the U.S., a study reports. Findings also showed that an intensification of…

Cognitive behavioral therapy (CBT) intervention can alleviate anxiety in people with chronic obstructive pulmonary disease (COPD), and reduce long-term hospital costs, a study shows. The results were published in the journal ERJ Open Research, in an article titled “Randomised controlled trial of cognitive behavioural therapy in…

Better and more adequate home-based care for patients with chronic obstructive pulmonary disease (COPD) can significantly improve their quality of life and reduce the need of hospital-based treatments. This finding was reported by the Canadian Foundation for Healthcare Improvement (CFHI) as a result of its INSPIRED initiative,…

Although studies show that continuous positive airway pressure (PAP) therapy can reduce hospitalizations among patients with chronic obstructive pulmonary disease (COPD), less than 8 percent of patients receive this treatment. PAP is a treatment delivered by a device that gently forces pressurized room air through the airways to keep the…

Using Monaghan Medical’s Aerobika device as part of a treatment regimen may help reduce emergency room visits, hospital re-admissions and related costs, as well as the recurrence of exacerbations in patients with chronic obstructive pulmonary disease (COPD). The study reporting these findings, “A Real-World Study of 30-Day Exacerbation…